Our guide to how herpes is transmitted goes into more detail about this, as well as prevention methods. Current scientific research shows that herpes is highly contagious and that everyone is at risk of infection. The good news is that, while there is no HSV-2 or HSV-1 vaccination, and while there's no such thing as HSV-1 or HSV-2 immunity, herpes is one of the easiest viruses to treat, with several highly effective medications available to help reduce the effects of herpes and speed up the healing process if you develop cold sores or genital herpes lesions.
Worried you might have herpes? Your best bet is to talk to your doctor about the symptoms you're experiencing. If they can't give a physical confirmation that you're a carrier, they'll be able to point you in the right direction about seeking a herpes test.
You can also learn more about herpes treatment options in our guide to valacyclovir Valtrex , a widely used medication that controls herpes outbreaks and reduces your risk of transmitting the virus to other people. This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment.
Insider tips, early access and more. What We Treat. By submitting your question, you agree to be answered by email. Your email address will only be used to answer your question unless you are an Academy member or are subscribed to Academy newsletters. About Foundation Museum of the Eye. Can I develop an immunity to medication for herpes? AUG 25, Question: I am 42 and suffer from herpes keratitis in my right eye that has caused corneal scarring but I am luckily still able to see OK.
Answer: In contrast to antibiotics, long-term use of herpetic anti-viral medications does not seem to increase the incidence of drug resistance. Ask an Ophthalmologist.
Browse Answers. Medical disclaimer By submitting your question, you agree to be answered by email. Question Required.
Email address Required. Additional concern for nephrotoxicity was also considered. Cidofovir is a nucleoside analogue antiviral drug with broad spectrum activity against DNA viruses. It works by inactivating viral DNA polymerase. Pharmacokinetics has been reported for IV administration of cidofovir, but only bioavailability studies have been performed for topical and subcutaneous administration of cidofovir.
On intact rabbit skin, the bioavailability of radiolabeled cidofovir has been shown to be 0. A review of the otorhinology literature for children and adults receiving IL cidofovir for laryngeal papillomas showed that administration of IL cidofovir was safe, without increased risk of dysplasia or carcinoma. Increased bioavailability combined with greater safety enabled successful treatment of disfiguring HSV in an HIV-positive patient. Our patient had completed therapy 3 months prior to this writing and has been free from HSV infection for 5 months.
Intralesional therapy enabled us to treat the HSV lesion resistant to acyclovir therapy without further compromising this patient's renal function. This patient will undergo reconstructive surgery after 6 months of being clear of HSV infection. Author Contributions: Drs Castelo-Soccio, Bernardin, and Stern had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Acquisition of data : Castelo-Soccio, Bernardin, and Goldstein. Analysis and interpretation of data : Goldstein. Drafting of the manuscript : Castelo-Soccio, Bernardin, and Kovarik. Critical revision of the manuscript for important intellectual content : Stern, Goldstein, and Kovarik. Study supervision : Kovarik. Clinicians, residents, and fellows are invited to submit cases of challenges in management and therapeutics to this section. Cases should follow the established pattern.
Manuscripts should be prepared double-spaced with right margins nonjustified. Clinical photographs, photomicrographs, and illustrations must be sharply focused and submitted as separate JPG files with each file numbered with the figure number.
Preliminary inquiries regarding submissions for this feature may be submitted to Erik J. Stratman, MD stratman. Arch Dermatol. Coronavirus Resource Center. Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy Continue. Save Preferences. Privacy Policy Terms of Use. Twitter Facebook. This Issue.
0コメント